According to numerous data, the concentrations of amyloid and tau proteins in the CSF signify neurodegenerative changes linked to AD, and these parameters form the foundation of the ATN classification system (amyloid, tau, and neurodegeneration) for identifying dementia types [34]. This evidence concerns the gene MAPT and dementia.